306 related articles for article (PubMed ID: 28440296)
1. Gold nanoclusters-assisted delivery of NGF siRNA for effective treatment of pancreatic cancer.
Lei Y; Tang L; Xie Y; Xianyu Y; Zhang L; Wang P; Hamada Y; Jiang K; Zheng W; Jiang X
Nat Commun; 2017 Apr; 8():15130. PubMed ID: 28440296
[TBL] [Abstract][Full Text] [Related]
2. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
3. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K
Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo.
Li C; Chen D; Luo M; Ge M; Zhu J
Biotechnol J; 2014 May; 9(5):652-63. PubMed ID: 24799381
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model.
Takakura K; Shibazaki Y; Yoneyama H; Fujii M; Hashiguchi T; Ito Z; Kajihara M; Misawa T; Homma S; Ohkusa T; Koido S
PLoS One; 2015; 10(12):e0142981. PubMed ID: 26642349
[TBL] [Abstract][Full Text] [Related]
6. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
[TBL] [Abstract][Full Text] [Related]
7. The effects of cyclooxygenase-2 gene silencing by siRNA on cell proliferation, cell apoptosis, cell cycle and tumorigenicity of Capan-2 human pancreatic cancer cells.
Zhong Y; Xia Z; Liu J; Lin Y; Zan H
Oncol Rep; 2012 Apr; 27(4):1003-10. PubMed ID: 22200969
[TBL] [Abstract][Full Text] [Related]
8. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
[TBL] [Abstract][Full Text] [Related]
9. Nek2 siRNA therapy using a portal venous port-catheter system for liver metastasis in pancreatic cancer.
Kokuryo T; Hibino S; Suzuki K; Watanabe K; Yokoyama Y; Nagino M; Senga T; Hamaguchi M
Cancer Sci; 2016 Sep; 107(9):1315-20. PubMed ID: 27316377
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
[TBL] [Abstract][Full Text] [Related]
11. PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.
Kim HJ; Oba M; Pittella F; Nomoto T; Cabral H; Matsumoto Y; Miyata K; Nishiyama N; Kataoka K
J Drug Target; 2012 Jan; 20(1):33-42. PubMed ID: 22066783
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer.
Dong D; Gao W; Liu Y; Qi XR
Cancer Lett; 2015 Apr; 359(2):178-86. PubMed ID: 25592040
[TBL] [Abstract][Full Text] [Related]
13. The Use of Star Polymer Nanoparticles for the Delivery of siRNA to Mouse Orthotopic Pancreatic Tumor Models.
McCarroll JA; Sharbeen G; Kavallaris M; Phillips PA
Methods Mol Biol; 2019; 1974():329-353. PubMed ID: 31099013
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo.
He XW; Liu T; Xiao Y; Feng YL; Cheng DJ; Tingting G; Zhang L; Zhang Y; Chen YX; Tingting G; Zhang L
Cancer Biother Radiopharm; 2009 Apr; 24(2):249-59. PubMed ID: 19409048
[TBL] [Abstract][Full Text] [Related]
15. RNAi-based therapeutic nanostrategy: IL-8 gene silencing in pancreatic cancer cells using gold nanorods delivery vehicles.
Panwar N; Yang C; Yin F; Yoon HS; Chuan TS; Yong KT
Nanotechnology; 2015 Sep; 26(36):365101. PubMed ID: 26291710
[TBL] [Abstract][Full Text] [Related]
16. A Rationally Optimized Nanoparticle System for the Delivery of RNA Interference Therapeutics into Pancreatic Tumors in Vivo.
Teo J; McCarroll JA; Boyer C; Youkhana J; Sagnella SM; Duong HT; Liu J; Sharbeen G; Goldstein D; Davis TP; Kavallaris M; Phillips PA
Biomacromolecules; 2016 Jul; 17(7):2337-51. PubMed ID: 27305597
[TBL] [Abstract][Full Text] [Related]
17. Nanoemulsion-Assisted siRNA Delivery to Modulate the Nervous Tumor Microenvironment in the Treatment of Pancreatic Cancer.
Ding L; Tang S; Yu A; Wang A; Tang W; Jia H; Oupický D
ACS Appl Mater Interfaces; 2022 Mar; 14(8):10015-10029. PubMed ID: 35188730
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
19. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
[TBL] [Abstract][Full Text] [Related]
20. siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo.
Hu P; Chen X; Sun J; Bie P; Zhang LD
Biosci Rep; 2015 Jan; 35(1):. PubMed ID: 25370920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]